Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antibiotic
|
| gptkbp:activeDuring |
gptkb:moxifloxacin
|
| gptkbp:brand |
gptkb:Avelox
|
| gptkbp:chemicalFormula |
C21H24FN3O4
|
| gptkbp:clinicalTrials |
Phase III
|
| gptkbp:contraindication |
gptkb:myasthenia_gravis
tendon disorders hypersensitivity to moxifloxacin |
| gptkbp:date |
1999
|
| gptkbp:dosageForm |
oral tablet
IV infusion |
| gptkbp:drugInterdiction |
fluoroquinolone
|
| gptkbp:formulation |
tablet
injection |
| gptkbp:gestationPeriod |
C
|
| gptkbp:hasFilm |
liver toxicity
tendon rupture QT prolongation |
| gptkbp:healthcare |
take with or without food
avoid excessive sun exposure do not take with dairy products report any tendon pain immediately stay hydrated during treatment |
| https://www.w3.org/2000/01/rdf-schema#label |
Avelox
|
| gptkbp:interactsWith |
NSAIDs
antacids diuretics warfarin theophylline |
| gptkbp:isATypeOf |
118716-47-4
|
| gptkbp:manufacturer |
gptkb:Bayer_AG
|
| gptkbp:marketedAs |
gptkb:Australia
gptkb:Canada gptkb:European_Union gptkb:Japan gptkb:United_States |
| gptkbp:numberOfStudents |
12 hours
|
| gptkbp:nutritionalValue |
liver
|
| gptkbp:operates_in |
J01MA14
|
| gptkbp:route |
oral
intravenous |
| gptkbp:shelfLife |
24 months
|
| gptkbp:sideEffect |
dizziness
headache nausea abdominal pain vomiting diarrhea rash insomnia |
| gptkbp:storage |
room temperature
protected from light |
| gptkbp:usedFor |
bacterial infections
|